Structure and function of placental growth factor

Trends in Cardiovascular Medicine

Volumn 12, Issue 6, 2002, Pages 241-246

  De Falco, Sandro ^a   Gigante, Bruna ^a   Persico, M Graziella ^a  

^a INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; PLACENTAL GROWTH FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL MODEL; BLOOD VESSEL; CARCINOGENESIS; CARDIOVASCULAR DISEASE; DEVELOPMENT; ENZYME REGULATION; GENE INACTIVATION; HUMAN; ISCHEMIA; ISCHEMIC HEART DISEASE; LIMB ISCHEMIA; MOUSE MUTANT; NONHUMAN; PATHOLOGY; PLACENTA; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN STRUCTURE; REPRODUCTION; REVIEW; STIMULATION;

EID: 0036701874     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(02)00168-8     Document Type: Review

References (40)

1. Bellomo D., Headrick J.P., Silins G.U.et al. Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia. Circ Res. 86:2000;29-35.
2. Cao Y., Chen H., Zhou L.et al. Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR. J Biol Chem. 271:1996;3154-3162.
3. Carmeliet P., Ferreira V., Breier G.et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature. 380:1996;435-439.
4. Carmeliet P., Jain R.K. Angiogenesis in cancer and other diseases. Nature. 407:2000;249-257.
5. Carmeliet P., Moons L., Luttun A.et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med. 7:2001;575-583.
6. 188. Nat Med. 5:1999;495-502.
7. Di Salvo J., Bayne M.L., Conn G.et al. Purification and characterization of a naturally occurring vascular endothelial growth factor-placenta growth factor. J Biol Chem. 270:1995;7717-7723.
8. Epstein S.E., Kornowsky R., Fuchs S., Dvorak H.F. Angiogenesis therapy, amidst the hype, the neglected potential for serious side effects. Circulation. 104:2001;115-119.
9. Ferrara N. Vascular endothelial growth factor. molecular and biological aspects Curr Top Microbiol Immunol. 237:1999;1-30.
10. Ferrara N., Carver-Moore K., Chen H.et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 380:1996;439-442.
11. Fong G.H., Rossant J., Gertsenstein M., Breitman M.L. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature. 376:1995;66-70.
12. Fujisawa H., Kitsukawa T. Receptors for collapsin/semaphorins. Curr Opin Neurobiol. 8:1998;587-592.
13. Gagnon M.L., Bielemberg D.R., Gechtman Z.et al. Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor. in vivo expression and antitumor activity Proc Natl Acad Sci USA. 97:2000;2573-2578.
14. Goldman C.K., Kendall R.L., Cabrera G.et al. Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate. Proc Natl Acad Sci USA. 95:1998;8795-8800.
15. Gurdon J.B., Bourillot P.Y. Morphogen gradient interpretation. Nature. 413:2001;797-803.
16. Hauser S., Weich H.A. A heparin-binding form of placenta growth factor (PlGF-2) is expressed in human umbilical vein endothelial cells and placenta. Growth Factors. 9:1993;259-268.
17. Hiratsuka S., Maru Y., Okada A.et al. Involvement of Flt-1 tyrosine kinase (vascular endothelial growth factor receptor-1) in pathological angiogenesis. Cancer Res. 61:2001;1207-1213.
18. Hiratsuka S., Minowa O., Kuno J.et al. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc Natl Acad Sci USA. 95:1998;9349-9354.
19. Ishida A., Murray J., Saito Y.et al. Expression of vascular endothelial growth factor receptors in smooth muscle cells. J Cell Physiol. 188:2001;359-368.
20. Isner J.M., Vale P.R., Symes J.F., Losordo D.W. Assessment of risks associated with cardiovascular gene therapy in human subjects. Circ Res. 89:2001;389-400.
21. Iyer S., Leonidas D.D., Swaminathan G.J.et al. The crystal structure of human placental growth factor-1 (PlGF-1), an angiogenic protein at 2.0 Å resolution. J Biol Chem. 276:2001;12,153-12,161.
22. Joukov V., Pajusola K., Kaipainen A.et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J. 15:1996;290-298.
23. Kawasaki T., Kitsukawa T., Bekku Y.et al. A requirement for neuropilin-1 in embryonic vessel formation. Development. 126:1999;4895-4902.
24. Maglione D., Guerriero V., Viglietto G.et al. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA. 88:1991;9267-9271.
25. Maglione D., Guerriero V., Viglietto G.et al. Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PlGF), are transcribed from a single gene of chromosome 14. Oncogene. 8:1993;925-931.
26. McDonald N.Q., Hendrickson W.A. A structural superfamily of growth factors containing a cystine knot motif. Cell. 73:1993;421-424.
27. McMahon G. VEGF receptor signaling in tumor angiogenesis. Oncologist. 5(Suppl 1):2001;3-10.
28. Moulton KS, Folkman J: 1999. Angiogenesis and cardiovascular disease. In Chien KR, ed. Molecular Basis of Cardiovascular Disease. Philadelphia, PA: W.B. Saunders, p 319.
29. Olofsson B., Pajusola K., von Euler G.et al. Genomic organization of the mouse and human genes for vascular endothelial growth factor B (VEGF-B) and characterization of a second splice isoform. J Biol Chem. 271:1996;19,310-19,317.
30. Orlandini M., Marconcini L., Ferruzzi R., Oliviero S. Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family. Proc Natl Acad Sci USA. 93:1996;11,675-11,680.
31. Park J.E., Chen H.H., Winer J.et al. Placenta growth factor. J Biol Chem. 269:1994;25,646-25,654.
32. Ramsden J.D. Angiogenesis in the thyroid gland. J Endocrinol. 166:2000;475-480.
33. Sato Y., Kanno S., Oda N.et al. Properties of two VEGF receptors, Flt-1 and KDR, in signal transduction. Ann NY Acad Sci. 902:2000;201-205.
34. Sawano A., Iwai S., Sakurai Y.et al. Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans. Blood. 97:2001;785-791.
35. Soker S., Takashima S., Miao H.et al. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell. 92:1998;735-745.
36. Tamagnone L., Artigiani S., Chen H.et al. Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell. 99:1999;71-80.
37. Thurston G., Rudje J.S., Ioff E.et al. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med. 6:2000;460-463.
38. Wiesmann C., Fuh G., Christinger H.W.et al. Crystal structure at 1.7 Å resolution of VEGF in complex with domain 2 of the Flt-1 receptor. Cell. 91:1997;695-704.
39. Wise L.M., Veikkola T., Mercer A.A.et al. Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1. Proc Natl Acad Sci USA. 96:1999;3071-3076.
40. Yancopoulos G.D., Davis S., Gale N.W.et al. Vascular-specific growth factors and blood vessel formation. Nature. 407:2000;242-248.